EQL Pharma AB
EQL SE0005497732
Sweden 222 23
SE-M Lund Stortorget 1
Registration Number 556713-3425
Founded 2006
Annual Performance 1
| 2024 |
|---|
| 29% |
Historical Performance 1
| 1M | 3M | 6M | 1Y | 3Y | 5Y | All Time |
|---|---|---|---|---|---|---|
| 18% | 43% | 0% | 0% | 0% | 0% | 29% |
Annual Insiders Turnover, USD 2
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| 119,274.78 | 1,801,477.04 | 2,136,245.00 | 476,160.49 | 938,579.32 | 5,983,090.02 | 526,538.46 |
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Transactions: 104 Insiders: 18
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Christer Fåhraeus CB |
60.00 SEK |
10,000 Sold |
600,000 SEK |
15/11/2024 | 14/11/2024 |
| Carl Lindgren EX OFF |
60.00 SEK |
10,000 Bought |
600,000 SEK |
15/11/2024 | 14/11/2024 |
| Christer Fåhraeus CB |
63.78 SEK |
26,000 Sold |
1,658,277 SEK |
15/11/2024 | 13/11/2024 |
| Martin Kristofferson EX OFF |
56.14 SEK |
5,000 Bought |
280,700 SEK |
04/10/2024 | 03/10/2024 |
| Axel Schörling CEO |
47.05 SEK |
53,903 Bought |
2,536,136 SEK |
27/05/2024 | 24/05/2024 |
| Christer Fåhraeus CB |
33.00 SEK |
300,000 Sold |
9,900,000 SEK |
12/12/2023 | 12/12/2023 |
| Carl Lindgren O |
30.00 SEK |
50,000 Bought |
1,500,000 SEK |
24/11/2023 | 23/11/2023 |
| Christer Fåhraeus CB |
30.22 SEK |
90,000 Sold |
2,719,800 SEK |
24/11/2023 | 23/11/2023 |
| Jimmie Johnsson O |
30.50 SEK |
125,000 Sold |
3,812,500 SEK |
14/06/2023 | 14/06/2023 |
| Christer Fåhraeus CB |
30.50 SEK |
1,000,000 Sold |
30,500,000 SEK |
14/06/2023 | 13/06/2023 |